Diagnos is a publicly traded Canadian corporation with a mission of early detection of critical health issues through the use of its artificial intelligence tool, CARA (computer-assisted retina analysis). CARA is accessible securely over the Internet, is compatible with all recognized image formats and brands of fundus cameras, and is EMR (electronic medical record) compatible. CARA is a cost-effective tool for screening large numbers of patients in real time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration, and the European Union.

1. SHARE STRUCTURE
$15.5M
172.4 M
STH-V HIGHLIGHTS
1.
2.
3.
4.
ABOUT
Diagnos Inc. is a leader in artificial intelligence and healthcare technical services including
algorithm development, data analysis, and image processing ever since 2001.
CARA, which has been developed by and is proprietary to Diagnos Inc., is an innovative
software program that uses enhanced digital images to support and identify the early
detection of vision loss and more specifically diabetic retinopathy. CARA is a
teleophthalmology platform which includes advanced retinal imaging technology and
clinical grading services by eye care professionals.
PRESENTS :
PUBLIC RELATIONS : MOMENTUM PR - 50 Rue de la Barre Longueuil, QC, J4K-5G2, Canada - Tel. 450-332-6939 - info@momentumpr.com
GLOBAL
SCREENING
$0.09
5.
REGULATORY
COMPLIANCE
Diagnos offers a tailored solution to public and parapublic organizations
(Governments).
Management has over 50 years of combined experience working on artificial
intelligence in the tech, science and healthcare space.
The AI market for healthcare applications is expected to achieve rapid
adoption globally, with a compound annual growth rate (CAGR) of 42% until
2021.
By 2020, chronic conditions such as cancer and diabetes are expected
to be diagnosed in minutes using cognitive systems.
Their proprietary technology CARA, integrates with almost any type of camera
allowing a seamless automation of detection of pathology in retinal photographs.
TO PREVENT
VISION LOSS
COUNTRIES SCREENING SITES PATIENTS
16 131 222,034
WHERE AI
BECOMES A
REALITY
ISO 9001: 2008 CERTIFIED
ISO 13485: 2003 CERTIFIED
CMDCAS (1) CERTIFIED
HEALTH CANADA APPROVED
FDA APPROVED
CE MARK APPROVED
OTCQB: DGNOF

2. PUBLIC RELATIONS : MOMENTUM PR - 50 Rue de la Barre Longueuil, QC, J4K-5G2, Canada - Tel. 450-332-6939 - info@momentumpr.com
DIABETES. A GLOBAL EMERGENCY.
Diagnos Inc.
7005 Taschereau Suite 340
Brossard, Québec
J4Z-1A7, Canada
450.678.8882
MANAGEMENT
André Larente- President & CEO
Mr Larente has been active in the information technology sector for more than 26 years. He has previously held
leading management positions with companies such as Siemens, Syscan International, Newbridge Networks, Legent
Corporation, Cognos, Tandem Computers and Honeywell Information Systems. His extensive business contacts and
experience in the information technology sector, have enabled him to position DIAGNOS for rapid growth.
Marc-André- Vice-President of Finance
Mr Massue joined the team in May 2008. He has more than 15 years of financial and human resources management
experience, acquired mainly with technology companies. Mr Massue’s main responsibilities include the preparation
of the annual and quarterly reports, the preparation of investment tax credits claims and the development and
monitoring of internal management policies. Mr Massue received a Bachelor in Business Administration (BBA) from
HEC Montréal, and a Diploma in Economics from the Université de Montréal. Mr Massue is a member of the Quebec
Order of Chartered Accountants.
Guillermo Moreno Robles- Vice-President of Sales
Mr. Moreno Robles joins DIAGNOS Inc., as Director-Business Development, with the aim of supporting strategic
deployment of corporation’s overseas business portfolio. Holding a Master in Economics (UIBE China), a Master in E-
Commerce (Tec de Monterrey Mexico) and BBA/Licence Commerce et Affaires Internationales (Université Lumière
Lyon 2 France), Mr. Moreno Robles’ competences and nine-years of proven experience in the world of business by
representing Mexico’s government in China-Asia Pacific region, providing economic consulting to investors,
coaching business promotion in the international arena, now takes part of DIAGNOS’ shared values and global
leadership in the IT private sector.
Yves Stéphane Couture- Vice-President of Sales
Sales professional with two decades of experience in IT and telecommunication. Mr. Couture is bringing key strategic
expertise from leading market innovator such as Teleglobe, Newbridge, Alcatel-Lucent and Nokia. During his career,
he led teams to sell and implement complex infrastructure solution in health care provider and hospitals while
bringing double digit growth in revenue for this vertical market. His experience, leadership and business acumen will
contribute to the rapid growth of Diagnos.
Dr. Hadi Chakor- Chief Medical Officer
Dr. Hadi Chakor MD, MSc, PhD successfully completed his medical school diploma with a specialization in
ophthalmology. He then further completed his master’s degree in biomedical engineering in the field of visual
electrophysiology (evaluation of the functional aspect of the retina) at the University of Montreal (2001-2003),
followed by a Doctorate (PhD) in biomedical sciences that specifically focused on the prevention of coronary heart
disease through the early presence of retinal microvascular abnormalities for a population at risk in collaboration
with the Montreal Heart Institute and the University of McGill’s department of ophthalmology .
His research was funded by the FRSQ and the FICM heart disease foundation. It should also be noted that he is the
recipient of the Jean-Louis Levesque Award, FICM 2011.
His expertise of over 20 years as a clinical researcher and consultant for various governmental bodies and
universities has led to my occupation of several research and development positions including being a researching
consultant for the National Health and Social Services Excellence Institute (INESS). He is the author and co-author of
50 national, international and institutional presentations and publications in the field of ophthalmology and I have
participated in the publication of several governmental reports on the prevention and optimization of health care in
Canada.
"All eyes have a story.
We help you read it through
artificial intelligence"
- André Larente, President & CEO
www.diagnos.ca